Brexpiprazole is used to treat certain mental/mood disorders such as schizophrenia, major depressive disorder, and dementia-associated agitation in patients with Alzheimer’s disease.

Brexpiprazole is used to treat certain mental/mood disorders such as schizophrenia, major depressive disorder, and dementia-associated agitation in patients with Alzheimer’s disease.

Buprenorphine/naloxone is the definitive partial agonist treatment for opioid use disorder (OUD).

Buprenorphine (Subutex, available now only as generic) is the active ingredient in Suboxone (buprenorphine/naloxone) and is responsible for the effectiveness of the combination medication in opioid use disorder. 

After you have initiated buprenorphine, see patients weekly at first to make sure the dose is right.

Induction refers to the process of starting a patient on buprenorphine (with or without naloxone; the combination product is most often preferred).

Buprenorphine alone was previously preferred for initial (induction) phase of treatment, with buprenorphine/naloxone combination preferred for maintenance treatment (unsupervised administration).